LBA12 - biomarkers Exploratory biomarkers in MONARCH 1, a phase II study of abemaciclib monotherapy in hormone-receptor positive (HR ) HER2- metastatic breast cancer (MBC)

Autor: Tolaney, S.M., Cortes, J., Dickler, M.N., Zamora, E., Caldwell, C.W., Nguyen, T.S., Nanda, S., Koustenis, A., Rugo, H.S.
Zdroj: In Annals of Oncology 1 October 2016 27 Supplement 6:vi552-vi552
Databáze: ScienceDirect